Hostname: page-component-7c8c6479df-7qhmt Total loading time: 0 Render date: 2024-03-29T12:09:26.913Z Has data issue: false hasContentIssue false

Interim statement on anti-dementia drugs

Implications, concerns and policy proposals

Published online by Cambridge University Press:  02 January 2018

Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
The College
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1997 The Royal College of Psychiatrists

References

Folstein, M. F., Folstein, S. E. & McHugh, P. A. (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.Google Scholar
Kelly, C. A., Harvey, R. I. & Cayton, H. (1977) Drug treatments for Alzheimer's disease. British Medical Journal, 314, 693694.Google Scholar
Royal College of Psychiatrists (1996) Consensus Statement on the Assessment and Investigation of an Elderly Person with Suspected Cognitive Impairment by a Specialist Old Age Psychiatry Service (Council Report CR49). London: Royal College of Psychiatrists.Google Scholar
World Health Organization (1992) The ICD–10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: WHO.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.